Kayne Anderson Rudnick Investment Management Llc increased its stake in Illumina Inc (ILMN) by 2.15% based on its latest 2017Q3 regulatory filing with the SEC. Kayne Anderson Rudnick Investment Management Llc bought 2,248 shares as the company’s stock rose 8.35% with the market. The institutional investor held 106,759 shares of the capital goods company at the end of 2017Q3, valued at $21.27M, up from 104,511 at the end of the previous reported quarter. Kayne Anderson Rudnick Investment Management Llc who had been investing in Illumina Inc for a number of months, seems to be bullish on the $33.31B market cap company. The stock decreased 1.15% or $2.63 during the last trading session, reaching $226.57. About 567,764 shares traded. Illumina, Inc. (NASDAQ:ILMN) has risen 28.24% since February 21, 2017 and is uptrending. It has outperformed by 11.54% the S&P500.
Neville Rodie & Shaw Inc decreased its stake in Merck & Company (MRK) by 2.65% based on its latest 2017Q3 regulatory filing with the SEC. Neville Rodie & Shaw Inc sold 7,807 shares as the company’s stock declined 2.46% while stock markets rallied. The institutional investor held 286,923 shares of the health care company at the end of 2017Q3, valued at $18.37M, down from 294,730 at the end of the previous reported quarter. Neville Rodie & Shaw Inc who had been investing in Merck & Company for a number of months, seems to be less bullish one the $149.79B market cap company. The stock decreased 2.33% or $1.31 during the last trading session, reaching $54.98. About 13.47M shares traded or 2.07% up from the average. Merck & Co., Inc. (NYSE:MRK) has risen 16.86% since February 21, 2017 and is uptrending. It has outperformed by 0.16% the S&P500.
Kayne Anderson Rudnick Investment Management Llc, which manages about $9.04 billion and $11.09B US Long portfolio, decreased its stake in Illinois Tool Works (NYSE:ITW) by 6,360 shares to 160,241 shares, valued at $23.71M in 2017Q3, according to the filing. It also reduced its holding in Broadridge Finl Soln (NYSE:BR) by 65,675 shares in the quarter, leaving it with 396,217 shares, and cut its stake in Baozun Inc.
Among 28 analysts covering Illumina Inc (NASDAQ:ILMN), 19 have Buy rating, 1 Sell and 8 Hold. Therefore 68% are positive. Illumina Inc had 95 analyst reports since July 22, 2015 according to SRatingsIntel. Barclays Capital maintained the shares of ILMN in report on Tuesday, April 19 with “Equal-Weight” rating. The stock has “Buy” rating by Argus Research on Wednesday, March 30. The rating was maintained by Piper Jaffray on Wednesday, October 21 with “Overweight”. The rating was maintained by Leerink Swann on Tuesday, April 19 with “Market Perform”. The firm earned “Neutral” rating on Monday, October 23 by Janney Capital. The firm has “Buy” rating by Robert W. Baird given on Thursday, January 18. As per Wednesday, September 13, the company rating was maintained by Argus Research. The firm has “Underweight” rating by Morgan Stanley given on Wednesday, December 7. The firm earned “Buy” rating on Wednesday, December 20 by Cowen & Co. The rating was downgraded by First Analysis on Wednesday, November 2 to “Underweight”.
Since August 28, 2017, it had 0 insider buys, and 20 sales for $39.38 million activity. 20,000 Illumina, Inc. (NASDAQ:ILMN) shares with value of $4.07 million were sold by FLATLEY JAY T. 2,000 shares were sold by Stapley Marc, worth $484,667. Dadswell Charles sold $29,323 worth of stock. Ronaghi Mostafa sold $4.20M worth of stock. 5,390 shares were sold by Bouchard Michel, worth $1.09M. Shares for $305,225 were sold by EPSTEIN ROBERT S.
Investors sentiment decreased to 1.1 in 2017 Q3. Its down 0.24, from 1.34 in 2017Q2. It turned negative, as 33 investors sold ILMN shares while 167 reduced holdings. 55 funds opened positions while 165 raised stakes. 131.54 million shares or 1.36% less from 133.36 million shares in 2017Q2 were reported. Greenleaf Tru, Michigan-based fund reported 9,063 shares. Advantus Management accumulated 0.08% or 14,911 shares. Adage Cap Prtn Gru Limited Liability accumulated 126,400 shares. Fdx Advsrs owns 1,847 shares for 0.01% of their portfolio. New York State Teachers Retirement Systems reported 212,852 shares. Japan-based Asset One Communication Limited has invested 0.11% in Illumina, Inc. (NASDAQ:ILMN). Boston Family Office Ltd Liability Company accumulated 0.1% or 4,429 shares. Creative Planning invested in 0.01% or 11,277 shares. 17,260 were accumulated by Mutual Of America Cap Mgmt Ltd Liability Corp. 1,900 are owned by Crestpoint Capital Mgmt Limited Liability. Reilly Financial Advisors Limited Liability Co holds 14 shares. Moreover, Lord Abbett & Lc has 0.1% invested in Illumina, Inc. (NASDAQ:ILMN). Her Majesty The Queen In Right Of The Province Of Alberta As Represented By Alberta Corporation accumulated 67,000 shares. 398,500 are held by Orbimed Advisors Ltd Liability. Perigon Wealth Mngmt Limited Liability Company holds 4,377 shares.
Among 24 analysts covering Merck & Co. Inc. (NYSE:MRK), 17 have Buy rating, 0 Sell and 7 Hold. Therefore 71% are positive. Merck & Co. Inc. had 79 analyst reports since August 13, 2015 according to SRatingsIntel. The firm earned “Neutral” rating on Wednesday, January 27 by Bank of America. The stock of Merck & Co., Inc. (NYSE:MRK) earned “Overweight” rating by Morgan Stanley on Thursday, January 12. The stock of Merck & Co., Inc. (NYSE:MRK) earned “Overweight” rating by JP Morgan on Monday, September 21. The stock of Merck & Co., Inc. (NYSE:MRK) earned “Outperform” rating by Credit Suisse on Wednesday, February 14. The company was maintained on Monday, July 17 by Deutsche Bank. The rating was upgraded by BNP Paribas to “Outperform” on Tuesday, August 18. The rating was maintained by Jefferies with “Hold” on Thursday, July 14. Jefferies maintained the shares of MRK in report on Tuesday, March 15 with “Hold” rating. As per Thursday, August 13, the company rating was upgraded by BMO Capital Markets. The firm has “Hold” rating by Jefferies given on Tuesday, January 16.
Analysts await Merck & Co., Inc. (NYSE:MRK) to report earnings on May, 1. They expect $0.98 earnings per share, up 11.36% or $0.10 from last year’s $0.88 per share. MRK’s profit will be $2.67B for 14.03 P/E if the $0.98 EPS becomes a reality. After $0.98 actual earnings per share reported by Merck & Co., Inc. for the previous quarter, Wall Street now forecasts 0.00% EPS growth.
Investors sentiment decreased to 1.06 in Q3 2017. Its down 0.01, from 1.07 in 2017Q2. It turned negative, as 46 investors sold MRK shares while 619 reduced holdings. 106 funds opened positions while 598 raised stakes. 1.96 billion shares or 0.47% more from 1.95 billion shares in 2017Q2 were reported. Hengehold Capital Ltd Liability Co, a Ohio-based fund reported 33,174 shares. Suntrust Banks holds 0.74% in Merck & Co., Inc. (NYSE:MRK) or 2.13M shares. Bankshares Of Nova Scotia has 762,562 shares. Barrow Hanley Mewhinney Strauss Lc has invested 1.46% in Merck & Co., Inc. (NYSE:MRK). E&G Lp has 0.38% invested in Merck & Co., Inc. (NYSE:MRK). Moreover, Congress Asset Co Ma has 0.78% invested in Merck & Co., Inc. (NYSE:MRK) for 788,128 shares. Aviance Capital Mgmt Ltd Co invested in 0% or 42 shares. Hemenway Trust Limited Liability Corporation holds 0.74% of its portfolio in Merck & Co., Inc. (NYSE:MRK) for 55,697 shares. Cypress Asset Management Tx reported 1.44% of its portfolio in Merck & Co., Inc. (NYSE:MRK). Davidson Advisors, Montana-based fund reported 4,928 shares. Oxbow Advisors Limited Liability Com reported 11,410 shares. Crestpoint Mgmt Limited holds 31,100 shares. Mathes holds 0.62% of its portfolio in Merck & Co., Inc. (NYSE:MRK) for 20,672 shares. Hbk Sorce Advisory Limited Liability Company has invested 0.19% in Merck & Co., Inc. (NYSE:MRK). 7.17 million are owned by Cap Rech Global.